Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2022-12-12

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2022-12-12

View Filing

CORRESP [Cover] - Correspondence

Form Type: CORRESP

Filing Date: 2022-12-08

View Filing

S-4/A [Amend] - Registration of securities, business combinations

Form Type: S-4/A

Filing Date: 2022-12-08

View Filing

UPLOAD [Cover] - SEC-generated letter

Form Type: UPLOAD

Filing Date: 2022-12-05

View Filing

PRE 14A - Other preliminary proxy statements

Form Type: PRE 14A

Filing Date: 2022-12-02

View Filing

425 - Prospectuses and communications, business combinations

Form Type: 425

Filing Date: 2022-12-02

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2022-12-02

View Filing

S-4 - Registration of securities, business combinations

Form Type: S-4

Filing Date: 2022-11-29

View Filing

425 - Prospectuses and communications, business combinations

Form Type: 425

Filing Date: 2022-10-19

View Filing